New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between Cytovation, Cancer Research UK and the Norwegian Cancer Society New ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by ...

Scientists develop lab-grown model of the human sensory pathway to investigate how pain signals are transmitted to the brain.

Researchers have recreated the human ascending sensory pathway in a lab dish, using organoids that model the key brain and ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

Immediate use for the newly developed assembloids could include studying neurodevelopmental disorders such as autism.

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

“There can be little doubt,” writes Fyodor Tertitskiy, that Kim Il Sung “is the darkest figure in all of Korea’s history.” If this Lord of Darkness has any competition at all, it comes ...

Phase 1 clinical trial of its investigational half-life extended anti-IL-23 monoclonal antibody, SPY003. This milestone marks our fourth on-time clinical trial initiation in nine months.

IL-1 signaling has roles in β-cell dysfunction and destruction via the NFκB and mitogen-activated-protein-kinase pathways, leading to endoplasmic reticulum and mitochondrial stress and ...